← Back to Screener
Claritev Corporation (CTEV)
Price$19.65
Favorite Metrics
Price vs S&P 500 (26W)-70.84%
Price vs S&P 500 (4W)10.95%
Market Capitalization$322.54M
All Metrics
P/CF (Annual)2.75x
Book Value / Share (Quarterly)$0.90
Revenue Growth (3Y)-3.66%
Cash Flow / Share (Quarterly)$-0.74
Price vs S&P 500 (YTD)-58.17%
Gross Margin (TTM)73.75%
Net Profit Margin (TTM)-29.45%
EPS (TTM)$-17.30
10-Day Avg Trading Volume0.08M
EPS Excl Extra (TTM)$-17.30
Revenue Growth (5Y)0.58%
EPS (Annual)$-17.30
ROI (Annual)-35.72%
Gross Margin (Annual)73.75%
Net Profit Margin (5Y Avg)-51.95%
Cash / Share (Quarterly)$1.02
Revenue Growth QoQ (YoY)6.21%
ROA (Last FY)-5.82%
Revenue Growth TTM (YoY)3.74%
EBITD / Share (TTM)$28.32
ROE (5Y Avg)-402.44%
Operating Margin (TTM)2.08%
Cash Flow / Share (Annual)$-0.74
P/B Ratio21.76x
P/B Ratio (Quarterly)22.87x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)5.08x
Net Interest Coverage (TTM)0.05x
ROA (TTM)-5.68%
EV / EBITDA (TTM)10.53x
EPS Incl Extra (Annual)$-17.30
Current Ratio (Annual)0.86x
Quick Ratio (Quarterly)0.69x
3-Month Avg Trading Volume0.21M
52-Week Price Return-8.30%
Revenue / Employee (TTM)$0
P/S Ratio (Annual)0.33x
Asset Turnover (Annual)0.20x
52-Week High$74.07
Operating Margin (5Y Avg)-25.66%
EPS Excl Extra (Annual)$-17.30
CapEx CAGR (5Y)12.85%
26-Week Price Return-66.86%
Quick Ratio (Annual)0.69x
13-Week Price Return-40.52%
Total Debt / Equity (Annual)53.83x
Current Ratio (Quarterly)0.86x
Enterprise Value$4,900.857
Revenue / Share Growth (5Y)96.76%
Asset Turnover (TTM)0.19x
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-38.64%
Cash / Share (Annual)$1.02
3-Month Return Std Dev115.18%
Gross Margin (5Y Avg)77.79%
Net Income / Employee (TTM)$-0
EBITDA CAGR (5Y)23.73%
ROE (Last FY)-1958.81%
Net Interest Coverage (Annual)0.05x
EPS Basic Excl Extra (Annual)$-17.30
P/FCF (TTM)4.42x
Receivables Turnover (TTM)8.88x
Total Debt / Equity (Quarterly)311.26x
EPS Incl Extra (TTM)$-17.30
Receivables Turnover (Annual)8.88x
ROI (TTM)-24.66%
P/S Ratio (TTM)0.33x
Pretax Margin (5Y Avg)-55.97%
Revenue / Share (Annual)$58.74
Price vs S&P 500 (52W)-38.13%
Year-to-Date Return-55.53%
5-Day Price Return6.32%
EPS Normalized (Annual)$-17.30
ROA (5Y Avg)-9.12%
Net Profit Margin (Annual)-29.45%
Month-to-Date Return16.34%
EBITD / Share (Annual)$28.32
Operating Margin (Annual)2.08%
LT Debt / Equity (Annual)53.67x
P/CF (TTM)2.75x
ROI (5Y Avg)-10.36%
LT Debt / Equity (Quarterly)310.26x
EPS Basic Excl Extra (TTM)$-17.30
P/B Ratio (Annual)2.83x
Pretax Margin (TTM)-38.64%
Book Value / Share (Annual)$5.19
Price vs S&P 500 (13W)-41.21%
Beta0.47x
P/FCF (Annual)5.13x
Revenue / Share (TTM)$58.41
ROE (TTM)-517.57%
52-Week Low$12.04
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.22
4.18
4.18
4.18
Industry Peers — Business Services(98)
| Symbol | P/E Ratio (Annual) | Revenue Growth (5Y) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|
CTEVClaritev Corporation | — | 0.58% | 2.08% | -517.57% | $19.65 |
VVISA Inc. | 29.77x | 12.86% | 59.18% | 54.22% | $315.10 |
MAMastercard Incorporated | 31.01x | 16.47% | 57.63% | 198.48% | $518.54 |
UBERUber Technologies, Inc. | 15.66x | 36.10% | 10.70% | 40.31% | $76.48 |
ACNAccenture PLC | 15.48x | 9.47% | 14.42% | 24.71% | $194.00 |
MELIMercado Libre, Inc | 47.55x | 48.70% | 11.08% | 33.73% | $1822.13 |
DASHDoorDash, Inc. Class A Common Stock | 83.60x | 36.58% | 5.27% | 10.15% | $179.33 |
RELXRELX PLC | 22.76x | 3.10% | 27.65% | 90.85% | $36.21 |
PYPLPayPal Holdings, Inc. Common Stock | 8.76x | 9.11% | 18.28% | 25.87% | $49.81 |
EBAYeBay Inc | 22.13x | 4.53% | 20.51% | 42.68% | $101.96 |
MSCIMSCI, Inc. | 34.27x | 13.08% | 54.67% | 108.67% | $564.90 |
About
Claritev Corp provides healthcare technology and data analytics solutions designed to improve cost management, transparency, and quality across the U.S. healthcare system. The company delivers customized, tech-enabled services encompassing payment integrity, network optimization, and revenue cycle analytics for healthcare providers and payers. Its data-driven platform helps organizations reduce costs while enhancing operational efficiency and affordability.